EPS Revision Screeners Spot Winners: RCEL +28.9%, FWRD +23.5%, AEHR +20.7%
On July 21, 2026, the EPS revision screener captured five stocks with strong gains since detection. RCEL surged 28.9% after its EPS growth estimate was revised to 48.4%, ahead of its Q2 earnings announcement. FWRD rose 23.5% on an 8.6 percentage point revision to 78.0%, while AEHR jumped 20.7% on a 20-point revision to 119.6%, supported by analyst upgrades in semiconductor testing. Smaller moves were seen in AIRS (+16.7%) and TPC (+11.0%), both driven by EPS revisions without company-specific news.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| RCEL | Healthcare | 2026-07-14 | N/A | +28.9% |
| FWRD | Industrials | 2026-07-14 | +8.6pp | +23.5% |
| AEHR | Technology | 2026-07-17 | +20.0pp | +20.7% |
| AIRS | Healthcare | 2026-07-13 | N/A | +16.7% |
| TPC | Industrials | 2026-07-14 | N/A | +11.0% |
Why did RCEL stock jump in July 2026?
RCEL jumped 28.9% (from $4.02 to $5.18) after analysts raised its forward EPS growth estimate to 48.4% on July 14.
The revision came ahead of AVITA Medical's Q2 2026 earnings release scheduled for August 6, fueling investor anticipation. The healthcare stock also benefited from the company's announcement of its earnings call, reinforcing positive sentiment around its wound care technology.
RCEL EPS revision history → · Screener snapshot from 2026-07-14 →
FAQ: RCEL
Why did RCEL stock jump?
RCEL gained 28.9% after analysts revised its EPS growth estimate upward to 48.4% on July 14, ahead of its Q2 earnings announcement.
Is RCEL a buy after the rally?
The EPS revision suggests improving fundamentals, but investors should consider the upcoming Q2 earnings report on August 6 for further confirmation.
What is RCEL's EPS growth estimate?
AVITA Medical's next-year EPS growth estimate is 48.4% as of July 14, 2026.
Why did FWRD stock jump in July 2026?
FWRD jumped 23.5% (from $12.79 to $15.80) after analysts raised its forward EPS growth estimate from 69.4% to 78.0% on July 14.
The 8.6 percentage point revision reflected improving margins in Forward Air's asset-light transportation model. The subsequent announcement of its Q2 earnings release on August 5 further boosted sentiment, confirming the revision's credibility.
FWRD EPS revision history → · Screener snapshot from 2026-07-14 →
FAQ: FWRD
Why did FWRD stock jump?
FWRD surged 23.5% after analysts boosted its next-year EPS growth estimate by 8.6 percentage points to 78.0% on July 14.
What caused FWRD's surge?
The EPS revision was followed by news of its Q2 earnings release on August 5, reinforcing positive expectations for the company's asset-light model.
Is FWRD a buy after the rally?
The significant EPS revision suggests strong earnings momentum, but investors should wait for the Q2 results in August to confirm the trend.
Why did AEHR stock jump in July 2026?
AEHR jumped 20.7% (from $81.05 to $97.86) after analysts raised its forward EPS growth estimate from 99.6% to 119.6% on July 17.
Multiple analysts upgraded the stock, citing AI-driven demand for semiconductor testing. Freedom Broker raised its price target to $110, implying further upside, and the EPS revision captured by the screener preceded a broader analyst upgrade cycle.
AEHR EPS revision history → · Screener snapshot from 2026-07-17 →
FAQ: AEHR
Why did AEHR stock jump?
AEHR rose 20.7% after its EPS growth estimate was revised sharply higher from 99.6% to 119.6% on July 17, followed by multiple analyst upgrades citing AI demand.
What caused AEHR's surge?
The surge was fueled by an upward EPS revision and analyst upgrades raising price targets to $110, driven by expectations for stronger semiconductor testing demand from AI.
Is AEHR a buy after the rally?
Analysts see further upside, with a consensus price target implying additional gains, but the stock has already rallied significantly this year.
Why did AIRS stock jump in July 2026?
AIRS jumped 16.7% (from $4.20 to $4.90) after analysts raised its forward EPS growth estimate to 44.8% on July 13.
The revision in the healthcare sector occurred without company-specific news, implying the move was driven by sector momentum or early analyst model updates. As a body contouring provider, AirSculpt Technologies may be benefiting from broader demand for elective procedures.
AIRS EPS revision history → · Screener snapshot from 2026-07-13 →
FAQ: AIRS
Why did AIRS stock jump?
AIRS gained 16.7% after analysts revised its next-year EPS growth estimate upward to 44.8% on July 13.
What caused AIRS's surge?
The rally was driven by an upward EPS revision in the healthcare sector, with no specific news, implying positive macro trends for medical aesthetics.
Is AIRS a buy after the rally?
The EPS revision indicates improving profitability, but investors should monitor upcoming earnings for validation.
Why did TPC stock jump in July 2026?
TPC jumped 11.0% (from $77.77 to $86.35) after analysts raised its forward EPS growth estimate to 53.7% on July 14.
The construction and engineering firm's EPS revision reflects strong backlog and infrastructure demand. The lack of company-specific news suggests the market assigned high conviction to the revision, pushing the stock higher steadily.
TPC EPS revision history → · Screener snapshot from 2026-07-14 →
FAQ: TPC
Why did TPC stock jump?
TPC rose 11% after analysts boosted its next-year EPS growth estimate to 53.7% on July 14, signaling strong infrastructure sector momentum.
What is TPC's EPS growth estimate?
Tutor Perini's next-year EPS growth estimate is 53.7% as of July 14, 2026.
Is TPC a buy after the rally?
The EPS revision reflects solid fundamentals, but the stock may have more room if infrastructure spending continues.
Today's top performers highlight the power of early EPS revision detection, with the strongest gains in healthcare and industrials. The market rewarded upward estimate changes, particularly those accompanied by earnings news or analyst upgrades.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →